Dimerix Limited

A$0.20As of Sun 8 Nov 2026, 12:00 UTC
ASX:DXBHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR 0.91%
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.36
PE TTM —
TSR TTM (59.80%)
Mkt cap A$123.1M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.202
(1.64%)
171.66%
Hold 11|6|6|2|7
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
17.59%
16.51%
6.59%
14.48%
Revenue$M
14.72
15.25
15.68
15.80
(3.94%)
0.16%
5.34%
7.60%
Peers (US$84.53M)
Cap (US$)
PE
84.40M
—
Capital
TTM
5Y
10Y
Leveragex
1.225
(0.020)
(0.019)
EBIT/Intx
0.449
0.517
0.472
Own earn%
(72.66)
47.10
45.77
Sh yield%
17.07
26.45
26.93
Owners
Insiders/Inst%
8.85
47.99
Short interest%
5.32
SBC / revenue%
4.82
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
6–12
$1 testx
—
Incr. ROIC%
2